MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Morepen Laboratories Ltd has informed BSE regarding Loss of Share Certificates of the Company20-05-2019
20-05-2019
MOREPEN LABORATORIES LTD. - 500288 - Clarification On Price Movement
With reference to significant movement in price, Morepen Laboratories Ltd has submitted to BSE a copy of Clarification which is enclosed herewith.10-05-2019
MOREPEN LABORATORIES LTD. - 500288 - Clarification Sought on Price Movement
The Exchange has sought clarification from Morepen Laboratories Ltd on May 09, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.09-05-2019
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that subsequent to the declaration of Audited Financial Results for the quarter and year ended 31st March, 2019, the Company is organizing an 'Investor and Analyst Conference Call' on Wednesday, 8th May, 2019 at 4.00 P.M. (IST).06-05-2019
Morepen Labs Q4 net up 54% at Rs 10.49 cr
Drug firm Morepen Laboratories on Monday reported a 54 per cent rise in its consolidated net profit at Rs 10.49 crore for the quarter ended March 31,06-05-2019
MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed the Investor Presentation based on the financial performance of the Company for the quarter and year ended 31st March, 2019.06-05-2019
MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the press release on the financial performance of the Company for the Quarter and Year ended 31st March, 2019 with the title - ''Morepen Labs profit rises by 125''Yc, in Q4 FY 2018-19 led by good growth in all business segments''.06-05-2019
MOREPEN LABORATORIES LTD. - 500288 - Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31St March, 2019
Board of Directors of the Company, in their meeting held on Saturday, 4th May, 2019 (commenced at 12.00 Noon and concluded at 04.00 P.M.), have, inter-alia, considered and approved the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2019, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.04-05-2019
MOREPEN LABORATORIES LTD. - 500288 - Outcome of Board Meeting
This is to inform you that the Board of Directors of the Company, in their meeting held on Saturday, 4th May, 2019 (commenced at 12.00 Noon and concluded at 04.00 P.M.), have, inter-alia, considered and approved the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2019, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. A copy of the 'Results' alongwith the Report of the Auditors of the Company, with unmodified opinion, thereon and a declaration to that effect is enclosed herewith.04-05-2019